Related Experiment Video
Updated: May 13, 2025

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
Generating Risk Reduction Analytics in Complex Cardiac Care Environments (GR2AC3E): Risk Prediction in Congenital
Brian P Quinn1, Lauren C Gunnelson1, Alex Case2
1Department of Cardiology, Boston Children's Hospital, Boston, Massachusetts.
Background:
Traditional statistical methodologies inadequately capture the complexities of real-world practice to assess risk in congenital cardiac catheterization (CCC). Artificial intelligence and machine learning (ML) techniques are well-suited to analyze preprocedural patient risk given the complexity and heterogeneity of infrequently performed CCC procedures. We sought to apply supervised ML analytics to an enterprise-level data set to enhance understanding of patient-, procedural-, and system-level risk in patients undergoing CCC.
Methods:
A comprehensive data set built from electronic health record metadata captured important patient-, procedural-, and system-level characteristics from 2019 through 2020 at Boston Children's Hospital for all patients undergoing diagnostic-only or interventional CCC. Supervised ML was used to develop random forest and least absolute shrinkage and selection operator (LASSO) models to predict the outcome of clinically meaningful adverse events. Models were trained on a randomly selected portion of the data set (75%) whereas the remaining data set (25%) was used for testing purposes. Model performance was evaluated using area under receiver operating characteristic curve and a plot showing the calibration between predicted probability deciles and observed probabilities of the model. Feature importance was assessed.
Results:
Our analysis included 1424 cases. Area under the receiver operating characteristic curve for the random forest and LASSO models were 0.67 and 0.68, respectively. Both algorithms exhibited better than random predictive ability with the LASSO model showing a superior level of calibration.
Conclusions:
Improving our understanding of risk during preprocedural assessment will inform clinical decision-making and allow for implementation of targeted risk mitigation strategies in high-risk patients to improve CCC patient outcomes.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Pulse rhythm
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Steps in Outbreak Investigation
Hazard Rate
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic...

